observed fewer HCC tumors in mice with hepatocyte-specific NOD2 or RIPK2 deficiency, whereas in mice with NOD2 knockout in both hepatocytes and hematopoietic cells, the number of HCC tumors was increased (51, 53). Here, NOD2 is linked to hepatocellular carcinoma.